Longitudinal Follow-up of High Viscosity Glassionomer IonoStar Plus Versus a Composite Bulk X-tra-Fil Combined With Futurabond U (Splith Mouth Study): Reunion Island, Circus of Mafate

NCT ID: NCT03568253

Last Updated: 2024-08-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

65 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-09-21

Study Completion Date

2023-05-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective is the longitudinal follow-up and comparison of the maintenance of the dental filling materials up to 24 months using the HVGIC IonoStar Plus versus Bulk X-Tra -Fil composite (Futurabond U adhesive system). 150 patients will be recruited in the Mafate dental health center. Patients with minimum 2 carious lesions (or multiple of 2, maximum 6) class I or II moderate not including the cusps, and touching the outside part of the middle of dentin. Assignment period will be 4 years: Inclusion period 18 months with 2 years following (6-month, 1 year and 2 years checking) and 3 months for statistical analysis and publications process Estimation of the parameters associated with a failure of the restoration at 24 months will follow the FDI scores. The Secondary objectives are to evaluate the caries risk of isolated population thanks to Cambra application and estimate the concordance of the judgment of maintaining the restoration between the expert in-situ and experts based on the images remotely.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Caries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Bulk fil composite

Group Type ACTIVE_COMPARATOR

Caries treatment

Intervention Type OTHER

Treatment by Bulk fil composite after randomization of the tooth

High viscosity glass ionomer

Group Type ACTIVE_COMPARATOR

Caries treatment

Intervention Type OTHER

Treatment by High viscosity glass ionomer after randomization of the tooth

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Caries treatment

Treatment by Bulk fil composite after randomization of the tooth

Intervention Type OTHER

Caries treatment

Treatment by High viscosity glass ionomer after randomization of the tooth

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient with 2 carious lesions (or multiple of 2) class I or II moderate not including the cusps, and touching the outside part of the middle of dentin
* Asymptomatic tooth or with a reversible pulp syndrome tooth
* Measured by pulp test (if not possible should not prevent the inclusion)
* Patient consultant in investigative testing center
* Patient of 18 to 70 years old
* Patient able to support care
* Patient able to understand care (no language barrier)
* Collect the informed consent signed after a period of reflection
* Be affiliated to a French social security scheme or recipient of such a regime
* Tooth with criteria for pulp vitality tests of pulp sensibility

Exclusion Criteria

* Patient under guardianship
* Pregnant or breastfeeding
* Patient at risk for infectious endocarditis
* Patient with severe periodontal disease (Pocket depth ≥ 5mm and/or mobility IV)
* Patient with an allergy to one of the materials used in the study
* Patient with an allergy to local anesthesia
* Patient with risks of infectious endocarditis
* Non-cooperative patient
* Participate in another ongoing biomedical research
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Montpellier

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Montpellier

Montpellier, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

7550

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.